H5N1 Avian Influenza Pre-pandemic Vaccine Strains in China

被引:2
|
作者
Bo Hong [1 ]
Dong Li Bo [1 ]
Zhang Ye [1 ]
Dong Jie [1 ]
Zou Shu Mei [1 ]
Gao Rong Bao [1 ]
Wang Da Yan [1 ]
Shu Yue Long [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Natl Hlth & Family Planning Commiss, Key Lab Med Virol, Beijing 102206, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
Influenza; H5N1; Pre-pandemic; Vaccine strains; REVERSE-GENETICS; A VIRUS; INFECTION;
D O I
10.3967/bes2014.111
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Objective To prepare the 4 candidate vaccine strains of H5N1 avian influenza virus isolated in China. Methods Recombinant viruses were rescued using reverse genetics. Neuraminidase (NA) and hemagglutinin (HA) segments of the A/Xinjiang/1/2006, A/Guangxi/1/2009, A/Hubei/1/2010, and A/Guangdong/1/2011 viruses were amplified by RT-PCR. Multibasic amino acid cleavage site of HA was removed and ligated into the pCIpolI vector for virus rescue. The recombinant viruses were evaluated by trypsin dependent assays. Their embryonate survival and antigenicity were compared with those of the respective wild-type viruses. Results The 4 recombinant viruses showed similar antigenicity compared with wild-type viruses, chicken embryo survival and trypsin-dependent characteristics. Conclusion The 4 recombinant viruses rescued using reverse genetics meet the criteria for classification of low pathogenic avian influenza strains, thus supporting the use of them for the development of seeds and production of pre-pandemic vaccines.
引用
收藏
页码:763 / 769
页数:7
相关论文
共 50 条
  • [1] H5N1 Avian Influenza Pre-pandemic Vaccine Strains in China
    BO Hong
    DONG Li Bo
    ZHANG Ye
    DONG Jie
    ZOU Shu Mei
    GAO Rong Bao
    WANG Da Yan
    SHU Yue Long
    BiomedicalandEnvironmentalSciences, 2014, 27 (10) : 763 - 769
  • [2] Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production
    Dong, Jie
    Matsuoka, Yumiko
    Maines, Taronna R.
    Swayne, David E.
    O'Neill, Eduardo
    Davis, C. Todd
    Van-Hoven, Neal
    Balish, Amanda
    Yu, Hong-jie
    Katz, Jacqueline M.
    Klimov, Alexander
    Cox, Nancy
    Li, De-xin
    Wang, Yu
    Guo, Yuan-ji
    Yang, Wei-zhong
    Donis, Ruben O.
    Shu, Yue-long
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2009, 3 (06) : 287 - 295
  • [3] Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines
    Milne, George
    Kelso, Joel
    Kelly, Heath
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2010, 7 (45) : 573 - 586
  • [4] H5N1 avian influenza in China
    Chen HuaLan
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2009, 52 (05): : 419 - 427
  • [5] H5N1 avian influenza in China
    HuaLan Chen
    Science in China Series C: Life Sciences, 2009, 52 : 419 - 427
  • [6] Comprehensive Analysis of Antibodies Induced by Vaccination with 4 Kinds of Avian Influenza H5N1 Pre-Pandemic Vaccines
    Ohshima, Nobuko
    Iba, Yoshitaka
    Kubota-Koketsu, Ritsuko
    Yamasaki, Ayami
    Majima, Keiko
    Kurosawa, Gene
    Hirano, Daisuke
    Yoshida, Shunji
    Sugiura, Mototaka
    Asano, Yoshizo
    Okuno, Yoshinobu
    Kurosawa, Yoshikazu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 22
  • [7] A(H5N1) avian influenza: a new pandemic?
    Di Guardo, Giovanni
    Roperto, Sante
    VETERINARY RECORD, 2024, 194 (12) : 484 - 484
  • [8] Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS)
    Oshansky, Christine M.
    Zhou, James
    Gao, Yonghong
    Schweinle, Jo Ellen
    Biscardi, Karen
    DeBeauchamp, Jennifer
    Pavetto, Corrina
    Wollish, Amy
    Webby, Richard J.
    Cioce, Vittoria
    Donis, Ruben O.
    Bright, Rick A.
    Armstrong, Kimberly
    Gibson, Laura
    Hylton, Penny
    Jackson, Angela
    King, James
    Little, James
    O'Hara, Michael
    Robinson-Wright, Katina
    Tresnjak-Smith, Silvija
    Walker, Robert
    Yeh, Bai
    Yeskey, Debra
    VACCINE, 2019, 37 (03) : 435 - 443
  • [9] Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly
    Vesikari, Timo
    Forsten, Aino
    Herbinger, Karl-Heinz
    Della Cioppa, Giovanni
    Beygo, Jenny
    Borkowski, Astrid
    Groth, Nicola
    Bennati, Mariaviviana
    von Sonnenburg, Frank
    VACCINE, 2012, 30 (07) : 1388 - 1396
  • [10] Control of avian influenza A H5N1 in China
    Wu, Wei
    LANCET INFECTIOUS DISEASES, 2009, 9 (08): : 460 - 461